Sinohealth Tech Endorses Fifth Amended & Restated Memorandum and Articles; Authorised Capital Set at US$20.00 Million

Bulletin Express06-18

Sinohealth Technology Holdings Limited (“Sinohealth Tech”) has adopted its Fifth Amended and Restated Memorandum and Articles of Association by special resolution dated 18 June 2026.

Key points:

• Authorised Share Capital – The company now has authorised capital of US$20.00 million, divided into 2.00 billion shares with a par value of US$0.01 each.

• Corporate Flexibility – Objects are “unrestricted,” enabling the company to engage in any lawful activity worldwide. – The board may issue shares with preferred, deferred or other special rights and may create redeemable shares, warrants and other convertible securities.

• Treasury Shares & Buy-backs – Shares repurchased may be cancelled or held as treasury shares, and treasury shares carry no voting or dividend rights while held by the company.

• Meetings & Voting – General meetings may be conducted physically, electronically or in hybrid form; two shareholders form a quorum. – Most corporate actions require an ordinary resolution (simple majority). – Certain matters—including alteration of the Memorandum & Articles—require a “Supermajority Resolution” passed by at least 75 % of votes cast.

• Board Structure – The company must have a minimum of two directors. – One-third of directors (or the nearest whole number) must retire by rotation at each annual general meeting; every director is subject to re-election at least once every three years. – Directors may appoint alternates and can delegate powers to committees.

• Dividend Framework – Dividends may be paid out of realised or unrealised profits or, with shareholder approval, from the share premium account or other distributable reserves. – Scrip dividends are permitted, allowing shareholders to receive dividends in fully-paid shares.

• Borrowing & Security – The board is empowered to borrow money and issue debentures or other securities, and to mortgage or charge company assets as security.

• Indemnity – Directors, officers and trustees acting for the company are indemnified against liabilities except those arising from fraud or dishonesty.

• Winding-up – On liquidation, surplus assets (after settling liabilities) will be distributed to shareholders in proportion to paid-up capital; distribution in specie is allowed with a Supermajority Resolution.

• Registered Office – The registered office is situated at 89 Nexus Way, Camana Bay, Grand Cayman, KY1-9009, Cayman Islands.

The updated constitutional document replaces all prior versions and provides the governing framework for Sinohealth Tech’s operations, capital management and corporate governance going forward.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment